TMHC Strangle Strategy
TMHC (Taylor Morrison Home Corporation), in the Consumer Cyclical sector, (Residential Construction industry), listed on NYSE.
Taylor Morrison Home Corporation, together with its subsidiaries, operates as a public homebuilder in the United States. The company designs, builds, and sells single and multi-family detached and attached homes; and develops lifestyle and master-planned communities. It also develops and constructs multi-use properties consisting of commercial space, retail, and multi-family properties under the Urban Form brand name; and offers title insurance and closing settlement services, as well as financial services. In addition, the company operates under the Taylor Morrison, William Lyon Signature, and Darling Homes brand names in Arizona, California, Colorado, Florida, Georgia, Nevada, North and South Carolina, Oregon, Texas, and Washington. Taylor Morrison Home Corporation was founded in 1936 and is headquartered in Scottsdale, Arizona.
TMHC (Taylor Morrison Home Corporation) trades in the Consumer Cyclical sector, specifically Residential Construction, with a market capitalization of approximately $5.30B, a trailing P/E of 8.11, a beta of 1.51 versus the broader market, a 52-week range of 54.58-72.5, average daily share volume of 1.3M, a public-listing history dating back to 2013, approximately 3K full-time employees. These structural characteristics shape how TMHC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.51 indicates TMHC has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 8.11 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a strangle on TMHC?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current TMHC snapshot
As of May 15, 2026, spot at $55.07, ATM IV 39.20%, IV rank 5.67%, expected move 11.24%. The strangle on TMHC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on TMHC specifically: TMHC IV at 39.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a TMHC strangle, with a market-implied 1-standard-deviation move of approximately 11.24% (roughly $6.19 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TMHC expiries trade a higher absolute premium for lower per-day decay. Position sizing on TMHC should anchor to the underlying notional of $55.07 per share and to the trader's directional view on TMHC stock.
TMHC strangle setup
The TMHC strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TMHC near $55.07, the first option leg uses a $57.82 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TMHC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TMHC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $57.82 | N/A |
| Buy 1 | Put | $52.32 | N/A |
TMHC strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
TMHC strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on TMHC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on TMHC
Strangles on TMHC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TMHC chain.
TMHC thesis for this strangle
The market-implied 1-standard-deviation range for TMHC extends from approximately $48.88 on the downside to $61.26 on the upside. A TMHC long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current TMHC IV rank near 5.67% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TMHC at 39.20%. As a Consumer Cyclical name, TMHC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TMHC-specific events.
TMHC strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TMHC positions also carry Consumer Cyclical sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TMHC alongside the broader basket even when TMHC-specific fundamentals are unchanged. Always rebuild the position from current TMHC chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on TMHC?
- A strangle on TMHC is the strangle strategy applied to TMHC (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With TMHC stock trading near $55.07, the strikes shown on this page are snapped to the nearest listed TMHC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TMHC strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the TMHC strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 39.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TMHC strangle?
- The breakeven for the TMHC strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TMHC market-implied 1-standard-deviation expected move is approximately 11.24%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on TMHC?
- Strangles on TMHC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the TMHC chain.
- How does current TMHC implied volatility affect this strangle?
- TMHC ATM IV is at 39.20% with IV rank near 5.67%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.